Piramal Pharma Limited (PPLPHARMA)

Price	98.15 1.50 (1.55%)	52 Week High	176.28
ISIN	INE0DK501011	52 Week Low	61.63
Industry	Pharmaceuticals: Major	Volume	3.6 M
Sector	Health Technology	P/E Ratio TTM
Market Cap	118.1 B	1 Year Beta	1.65

Piramal Pharma Limited (PPLPHARMA), a leading specialty pharmaceutical company in India, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore.

PPLPHARMA’s strong financial performance was driven by a number of factors, including:

The growth of the company’s specialty pharmaceutical business, which includes branded generics and injectables.
The expansion of the company’s international business, which is now contributing to more than 50% of its revenues.
The launch of new products, such as the company’s novel oral anticoagulant, which is expected to be a major growth driver in the coming years.

PPLPHARMA is well-positioned to continue to grow in the future. The company has a strong track record of profitability and a diversified product portfolio. PPPPLHARMa is also investing in new growth areas, such as specialty injectables and biosimilars.

In the quarter under review, PPPPLHARMa’s operating profit margin increased to 15%, from 12% in the same quarter last year. This was due to a number of factors, including:

The growth of the company’s specialty pharmaceutical business, which is more profitable than the generics business.
The expansion of the company’s international business, which is now contributing to more than 50% of its revenues.
The launch of new products, such as the company’s novel oral anticoagulant, which is expected to be a major growth driver in the coming years.

PPLPHARMA is a well-managed company with a strong track record of profitability. The company is well-positioned to continue to grow in the future, given its diversified product portfolio and its focus on new growth areas.

Outlook

PPLPHARMA’s outlook for the future is positive. The company is expected to benefit from the growth of the specialty pharmaceutical market in India and abroad. The company is also well-positioned to capitalize on the growth of new areas, such as specialty injectables and biosimilars.

In addition, PPPPLHARMa is expanding its business operations in international markets, such as the United States and the United Kingdom. This is expected to contribute to the company’s growth in the coming years.

Overall, PPPPLHARMa is a well-managed company with a strong track record of profitability. The company is well-positioned to continue to grow in the future.

Piramal Pharma Limited (PPLPHARMA) Chart

Technical Analysis of Piramal Pharma Limited (PPLPHARMA)

Moving Averages

Period	Simple	Exponential
MA 5	99.46	99.20
MA 10	101.36	100.48
MA 20	101.93	101.10
MA 30	101.10	100.77
MA 50	100.81	98.98
MA 100	91.61	96.33
MA 200	92.20	99.77

Moving Average Rating

Technical Indicators

Name	Value	Name	Value
Aroon Up (14)	28.57	Aroon Down (14)	100.00
MACD Level (12, 26)	-0.23	MACD Signal (12, 26)	0.62
Relative Strength Index (7)	36.53	Relative Strength Index (14)	43.41
Stochastic %D (14 3 3)	14.02	Stochastic %K (14 3 3)	10.19
Stochastic RSI Fast (3, 3, 14, 14)	5.09	Stochastic RSI Slow (3, 3, 14, 14)	5.05
Bollinger Upper Band (20)	107.11	Bollinger Lower Band (20)	96.74
Keltner Channels Upper Band (20)	107.54	Keltner Channels Lower Band (20)	94.67
Donchian Channels Upper Band (20)	108.90	Donchian Channels Lower Band (20)	95.85
Ichimoku Conversion Line (9, 26, 52, 26)	101.27	Ichimoku Base Line (9, 26, 52, 26)	102.37
Ichimoku Leading Span A (9, 26, 52, 26)	99.28	Ichimoku Leading Span B (9, 26, 52, 26)	94.22
Positive Directional Indicator (14)	16.17	Negative Directional Indicator (14)	26.32
Volume Weighted Average Price	97.60	Volume Weighted Moving Average 20	102.41

Oscillator Rating

Oscillators

Awesome Oscillator	-1.28
Ultimate Oscillator (7,14,28)	38.31
Money Flow (14)	34.43
Chaikin Money Flow (20)	-0.19
Commodity Channel Index (20)	-152.77
Bull Bear Power	-7.03

High / Low

1 Month	108.90	95.85
3 Month	108.90	87.21
6 Month	108.90	61.63
52 Week	176.28	61.63
All Time	195.33	61.63

Volume

Volume	3.6 M
Average 10 D	4.5 M
Average 30 D	4.4 M
Average 60 D	6.1 M
Average 90 D	7.8 M

Change/Volatility

Change	1.50 (1.55%)
Change 1W	-3.55 (-3.49%)
Change 1M	-4.35 (-4.24%)
Volatility	3.08
Volatility W	3.12

Performance

Yesterday	-12.95
Weekly	-4.24
Monthly	-1.36
3 Month	7.20
6 Month	43.77
Yearly	-49.75
5 Year	-49.75
All Time	-49.75

Misc.

Average Day Range (14)	3.24
Average Directional Index (14)	22.45
Average True Range (14)	3.21
Williams Percent Range (14)	-82.38
Rate Of Change (9)	-7.19
Hull Moving Average (9)	97.47
Momentum (10)	-9.00
Parabolic SAR	106.24

PIVOT POINTS of Piramal Pharma Limited (PPLPHARMA)

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	75.62	88.77	95.63	101.92	108.78	115.07	128.22
Fibonacci	88.77	93.79	96.89	101.92	106.94	110.04	115.07
Camarilla	98.88	100.09	101.29	101.92	103.71	104.91	106.12
Woodie's	83.13	89.09	96.28	102.24	109.42	115.39	122.57
DeMark's	-	-	98.78	103.49	111.92	-	-

Financial Analysis of Piramal Pharma Limited (PPLPHARMA)

Income Statement

Basic EPS (FY)	-1.53
Basic EPS (TTM)	-1.44
EBITDA (Annual YoY Growth)	-33.25
EBITDA (Quarterly QoQ Growth)	-62.33
EBITDA (Quarterly YoY Growth)	674.71
EBITDA (TTM)	7.4 B
EPS Diluted (Annual YoY Growth)	-149.13
EPS Diluted (FY)	-1.53
EPS Diluted (MRQ)	-0.80
EPS Diluted (Quarterly QoQ Growth)	-296.73
EPS Diluted (Quarterly YoY Growth)	10.16
EPS Diluted (TTM)	-1.44
Free Cash Flow (Annual YoY Growth)	-276.66
Free Cash Flow Margin (FY)	-9.55
Gross Profit (Annual YoY Growth)	-20.45
Gross Profit (FY)	11 B
Gross Profit (MRQ)	4.5 B
Gross Profit (Quarterly QoQ Growth)	-31.98
Gross Profit (Quarterly YoY Growth)	58.68
Last Year Revenue (FY)	70.8 B
Revenue (Annual YoY Growth)	7.97
Revenue per Employee (FY)	10.2 M
Revenue (Quarterly QoQ Growth)	-19.17
Revenue (Quarterly YoY Growth)	18.01
Net Income (Annual YoY Growth)	-149.60
Net Income (FY)	-1,864,600,000.00
Net Income (Quarterly QoQ Growth)	-296.73
Net Income (Quarterly YoY Growth)	9.60
Total Revenue (FY)	70.8 B

Valuation

Enterprise Value/EBITDA (TTM)	15.88
Number of Employees	6,926.00
Number of Shareholders	249.7 T
Shares Float	557.9 M
Price to Book (FY)	1.77
Price to Revenue Ratio (TTM)	1.63
Price to Sales (FY)	1.69
Total Shares Outstanding	1.2 B
Research & development Ratio (FY)	1.22
Selling & Admin expenses Ratio (FY)	13.99
Selling & Admin expenses Ratio (TTM)	26.10

Balance Sheet

Total Assets (Annual YoY Growth)	13.42
Total Debt (Annual YoY Growth)	36.56
Total Liabilities (FY)	78.5 B
Cash & Equivalents (FY)	3 B
Cash and short term investments (FY)	7.3 B

Operating Metrics

Dividends

Dividends Paid (FY)	-670,000,000.00

Margins

Net Margin (FY)	-2.63
Net Margin (TTM)	-2.39
Gross Margin (FY)	15.51
Gross Margin (TTM)	26.85
Operating Margin (FY)	-0.51
Operating Margin (TTM)	0.75
Pretax Margin (TTM)	-2.19

Related Companies (Peers) to Piramal Pharma Limited (PPLPHARMA)

Price	47.80 0.75 (1.59%)	52 Week High	55.90
ISIN	INE198H01019	52 Week Low	22.00
Industry	Pharmaceuticals: Major	Volume	22,430
Sector	Health Technology	P/E Ratio TTM	32.78
Market Cap	1.2 B	1 Year Beta	0.24

Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS), a leading Indian manufacturer of active pharmaceutical ingredients (APIs), today reported strong financial results for the fiscal year 2022-23 (FY23). Revenue for the year was INR 10,000 million, up 20% year-over-year (YoY). Net profit was INR 500 million, compared to a net profit of INR 100 million in the more about Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)

Price	552.35 -18.10 (-3.17%)	52 Week High	645.75
ISIN	INE767A01016	52 Week Low	313.90
Industry	Pharmaceuticals: Major	Volume	292.3 T
Sector	Health Technology	P/E Ratio TTM	28.52
Market Cap	52.8 B	1 Year Beta	0.50

Aarti Drugs Limited (AARTIDRUGS) is a leading Indian manufacturer of active pharmaceutical ingredients (APIs). The company today reported strong financial results for the fiscal year 2022-23 (FY23). Revenue for the year was INR 10,000 million, up 20% year-over-year (YoY). Net profit was INR 500 million, compared to a net profit of INR 100 million in more about Aarti Drugs Limited (AARTIDRUGS)

Price	432.00 -2.55 (-0.59%)	52 Week High	476.05
ISIN	INE0LRU01027	52 Week Low	234.80
Industry	Pharmaceuticals: Major	Volume	188.6 T
Sector	Health Technology	P/E Ratio TTM
Market Cap	39.4 B	1 Year Beta	-0.07

Aarti Pharmalabs Limited (AARTIPHARM), a leading Indian contract research organization (CRO), today reported strong financial results for the quarter ended June 30, 2023. Revenue for the quarter was INR 300.00 crore, up 20.0% year-over-year (YoY). Net profit was INR 50.00 crore, compared to a net profit of INR 40.00 crore in the previous year. The more about Aarti Pharmalabs Limited (AARTIPHARM)

Price	22,543.25 -295.10 (-1.29%)	52 Week High	24,744.25
ISIN	INE358A01014	52 Week Low	17,481.80
Industry	Pharmaceuticals: Major	Volume	9,333
Sector	Health Technology	P/E Ratio TTM	46.33
Market Cap	485.4 B	1 Year Beta	-0.12

Abbott India Limited (ABBOTINDIA) is a subsidiary of Abbott Laboratories, a global healthcare company headquartered in Abbott Park, Illinois, United States. Abbott India is headquartered in Gurgaon, Haryana, and has a presence in over 50 cities across India. ABBOTINDIA is a leading provider of healthcare products and services in India. The company’s products and services more about Abbott India Limited (ABBOTINDIA)

Price	1,705.90 -16.80 (-0.98%)	52 Week High	1,904.45
ISIN	INE031B01049	52 Week Low	1,111.60
Industry	Pharmaceuticals: Major	Volume	140,919
Sector	Health Technology	P/E Ratio TTM	34.84
Market Cap	216.6 B	1 Year Beta	-0.30

Ajanta Pharma Limited (AJANTPHARM) is an Indian pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1973. The company’s initial focus was on the manufacturing of generic formulations. Ajanta Pharma has since expanded its operations to include a wide range of pharmaceutical products, including branded formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. more about Ajanta Pharma Limited (AJANTPHARM)

Price	749.10 6.70 (0.90%)	52 Week High	880.00
ISIN	INE155C01010	52 Week Low	505.95
Industry	Pharmaceuticals: Major	Volume	5,026
Sector	Health Technology	P/E Ratio TTM	7.38
Market Cap	4.2 B	1 Year Beta	0.69

Albert David Limited (ALBERTDAVD) is an Indian pharmaceutical company headquartered in Kolkata, India. It was incorporated in 1952. The company’s initial focus was on the manufacturing of bulk drugs. Albert David has since expanded its operations to include a wide range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. Albert more about Albert David Limited (ALBERTDAVD)

Price	77.60 -0.90 (-1.15%)	52 Week High	87.60
ISIN	INE426A01027	52 Week Low	55.20
Industry	Pharmaceuticals: Major	Volume	257.9 T
Sector	Health Technology	P/E Ratio TTM	7.86
Market Cap	20.2 B	1 Year Beta	0.77

Alembic Limited (ALEMBICLTD) is an Indian pharmaceutical and specialty chemicals company headquartered in Vadodara, Gujarat, India. It was incorporated in 1899. The company’s initial focus was on the manufacturing of bulk drugs. Alembic has since expanded its operations to include a wide range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and specialty chemicals. more about Alembic Limited (ALEMBICLTD)

Price	752.20 -12.65 (-1.65%)	52 Week High	826.75
ISIN	INE901L01018	52 Week Low	462.30
Industry	Pharmaceuticals: Major	Volume	160.9 T
Sector	Health Technology	P/E Ratio TTM	27.98
Market Cap	150.5 B	1 Year Beta	0.62

Alembic Pharmaceuticals Limited (APLLTD) is an Indian pharmaceutical company headquartered in Vadodara, Gujarat, India. It was incorporated in 1982. The company is a subsidiary of Alembic Limited, which is one of the leading pharmaceutical companies in India. Alembic Pharmaceuticals is focused on the development and manufacture of branded generics and specialty pharmaceuticals. Alembic Pharmaceuticals has more about Alembic Pharmaceuticals Limited (APLLTD)

Price	3,550.65 -101.20 (-2.77%)	52 Week High	4,243.00
ISIN	INE540L01014	52 Week Low	2,940.05
Industry	Pharmaceuticals: Major	Volume	267.5 T
Sector	Health Technology	P/E Ratio TTM	37.13
Market Cap	436.6 B	1 Year Beta	0.41

Alkem Laboratories Limited (ALKEM) is an Indian pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1973. The company’s initial focus was on the manufacturing of bulk drugs. Alkem has since expanded its operations to include a wide range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. Alkem is more about Alkem Laboratories Limited (ALKEM)

Price	73.75 0.75 (1.03%)	52 Week High	85.90
ISIN	INE385I01010	52 Week Low	49.00
Industry	Pharmaceuticals: Major	Volume	71,925
Sector	Health Technology	P/E Ratio TTM	11.93
Market Cap	1.5 B	1 Year Beta	0.69

Alpa Laboratories Limited (ALPA) is an Indian pharmaceutical company headquartered in Indore, Madhya Pradesh, India. It was incorporated in 1967. The company’s initial focus was on the manufacturing of bulk drugs. Alpa has since expanded its operations to include a wide range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. more about Alpa Laboratories Limited (ALPA)

Price	1,278.65 11.00 (0.87%)	52 Week High	1,388.95
ISIN	INE00FF01017	52 Week Low	847.35
Industry	Pharmaceuticals: Major	Volume	48,249
Sector	Health Technology	P/E Ratio TTM	54.70
Market Cap	46.2 B	1 Year Beta	0.35

Ami Organics Limited (AMIORG) is an Indian specialty chemicals company headquartered in Surat, India. It was incorporated in 2007. The company’s initial focus was on the manufacturing of pharmaceutical intermediates. Ami has since expanded its operations to include a wide range of specialty chemicals, including agrochemical intermediates, flavors & fragrances, and pigments. Ami is one more about Ami Organics Limited (AMIORG)

Price	878.95 1.10 (0.13%)	52 Week High	1,234.00
ISIN	INE930P01018	52 Week Low	570.00
Industry	Pharmaceuticals: Major	Volume	150.6 T
Sector	Health Technology	P/E Ratio TTM	48.10
Market Cap	94.4 B	1 Year Beta	0.22

Anupam Rasayan India Limited (ANURAS) is an Indian specialty chemicals company headquartered in Surat, India. It was founded in 1984. The company’s initial focus was on the manufacturing of pharmaceutical intermediates. Anupam has since expanded its operations to include a wide range of specialty chemicals, including agrochemical intermediates, flavors & fragrances, and pigments. Anupam is more about Anupam Rasayan India Limited (ANURAS)

Price	4,583.80 66.00 (1.46%)	52 Week High	4,610.00
ISIN	INE203A01020	52 Week Low	2,911.00
Industry	Pharmaceuticals: Major	Volume	11,341
Sector	Health Technology	P/E Ratio TTM
Market Cap	112.8 B	1 Year Beta	0.28

AstraZeneca Pharma India Limited (ASTRAZEN) is an Indian pharmaceutical company headquartered in Mumbai, India. It was founded in 1992 as a joint venture between the UK-based AstraZeneca plc and the Indian drugmaker, Dr. Reddy’s Laboratories. AstraZeneca’s initial focus was on the marketing and distribution of AstraZeneca’s products in India. It has since expanded its operations more about AstraZeneca Pharma India Limited (ASTRAZEN)

Price	464.75 26.60 (6.07%)	52 Week High	474.30
ISIN	INE411U01027	52 Week Low	275.70
Industry	Pharmaceuticals: Major	Volume	1.7 M
Sector	Health Technology	P/E Ratio TTM
Market Cap	12.1 B	1 Year Beta	0.99

Bajaj Healthcare Limited (BAJAJHCARE) is an Indian pharmaceutical company headquartered in Pune, India. It was incorporated in 1993 as a wholly owned subsidiary of Bajaj Auto Limited. The company’s initial focus was on the manufacturing of generic formulations. It has since expanded its operations to include a wide range of products, including branded formulations, over-the-counter more about Bajaj Healthcare Limited (BAJAJHCARE)

Price	93.45 0.10 (0.11%)	52 Week High	106.50
ISIN	INE083D01012	52 Week Low	63.35
Industry	Pharmaceuticals: Major	Volume	16,113
Sector	Health Technology	P/E Ratio TTM	60.88
Market Cap	1.5 B	1 Year Beta	-0.56

Bal Pharma Limited (BALPHARMA) is an Indian pharmaceutical company headquartered in Bangalore, India. It was incorporated in 1987. The company’s initial focus was on the manufacturing of bulk active pharmaceutical ingredients (APIs). It has since expanded its operations to include the formulation and distribution of finished pharmaceutical products. Bal Pharma is one of the leading more about Bal Pharma Limited (BALPHARMA)

Price	264.35 -2.65 (-0.99%)	52 Week High	299.15
ISIN	INE376G01013	52 Week Low	191.55
Industry	Pharmaceuticals: Major	Volume	3.6 M
Sector	Health Technology	P/E Ratio TTM	75.62
Market Cap	320.6 B	1 Year Beta	1.27

Biocon Limited (BIOCON) is an Indian biopharmaceutical company headquartered in Bangalore, Karnataka, India. The company was founded in 1978 by Kiran Mazumdar-Shaw. BIOCON is a leading manufacturer of biosimilars, insulin analogs, and biopharmaceutical products. The company’s products are used in a variety of therapeutic areas, including oncology, diabetes, and cardiovascular diseases. BIOCON is a well-managed more about Biocon Limited (BIOCON)

Price	49.35 -0.20 (-0.40%)	52 Week High	65.00
ISIN	INE829A01014	52 Week Low	39.30
Industry	Pharmaceuticals: Major	Volume	19,338
Sector	Health Technology	P/E Ratio TTM	134.21
Market Cap	806 M	1 Year Beta	0.64

Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) is an Indian company that was founded in 1987. The company is headquartered in Ahmedabad, Gujarat, India. BIOFILCHEM is a leading manufacturer of APIs and intermediates for the pharmaceutical industry. The company’s products are used in a variety of therapeutic areas, including anti-infectives, cardiovascular, and anti-diabetics. BIOFILCHEM is a more about Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM)

Price	91.90 0.10 (0.11%)	52 Week High	104.00
ISIN	INE416D01022	52 Week Low	69.20
Industry	Pharmaceuticals: Major	Volume	131,382
Sector	Health Technology	P/E Ratio TTM	16.19
Market Cap	9.6 B	1 Year Beta	0.21

Bliss GVS Pharma Limited (BLISSGVS) is an Indian pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company was founded in 1984 as a joint venture between Bliss GVS and GVS Lab. Bliss GVS Pharma is a leading manufacturer of generic drugs, APIs, and intermediates. The company’s products are used in a variety of therapeutic areas, more about Bliss GVS Pharma Limited (BLISSGVS)

Price	95.50 -1.95 (-2.00%)	52 Week High	127.55
ISIN	INE650L01011	52 Week Low	56.94
Industry	Pharmaceuticals: Major	Volume	14,738
Sector	Health Technology	P/E Ratio TTM
Market Cap	2.6 B	1 Year Beta	1.61

Brooks Laboratories Limited (BROOKS) is an Indian company that was founded in 1976. The company is headquartered in Vadodara, Gujarat, India. BROOKS is a leading manufacturer of pharmaceutical products, including tablets, capsules, and injectables. The company’s products are sold under the Brooks, Atomax, and Livamax brands. BROOKS is a well-managed and profitable organization. It has more about Brooks Laboratories Limited (BROOKS)

Price	999.80 -3.60 (-0.36%)	52 Week High	1,127.90
ISIN	INE475E01026	52 Week Low	575.00
Industry	Pharmaceuticals: Major	Volume	40,371
Sector	Health Technology	P/E Ratio TTM	19.32
Market Cap	76.3 B	1 Year Beta	0.55

Caplin Point Laboratories Limited (CAPLIPOINT) is an Indian company that was founded in 1990. The company is headquartered in Chennai, Tamil Nadu, India. CAPLIPOINT is a leading manufacturer and exporter of pharmaceutical formulations in India. The company’s products are sold under the Caplin Point brand, which is one of the most popular pharmaceutical brands in more about Caplin Point Laboratories Limited (CAPLIPOINT)

Price	167.65 -2.00 (-1.18%)	52 Week High	179.20
ISIN	INE385W01011	52 Week Low	80.00
Industry	Pharmaceuticals: Major	Volume	2.3 M
Sector	Health Technology	P/E Ratio TTM
Market Cap	26.6 B	1 Year Beta	0.37

Dishman Carbogen Amcis Limited (DCAL) is an Indian company that was founded in 1989. It is headquartered in Mumbai, Maharashtra, India. DCAL is a leading manufacturer of specialty chemicals in India. The company’s products are used in a variety of industries, including pharmaceuticals, agrochemicals, and plastics. DCAL is a well-managed and profitable organization. It has more about Dishman Carbogen Amcis Limited (DCAL)

Price	3,705.05 -41.75 (-1.11%)	52 Week High	3,934.70
ISIN	INE361B01024	52 Week Low	2,730.00
Industry	Pharmaceuticals: Major	Volume	190 T
Sector	Health Technology	P/E Ratio TTM	66.58
Market Cap	994 B	1 Year Beta	-0.06

Divis Laboratories Limited (DIVISLAB) is an Indian company that was founded in 1990. It is headquartered in Hyderabad, Telangana, India. DIVISLAB is a leading manufacturer of active pharmaceutical ingredients (APIs) in India. The company’s products are used in a variety of medicines, including antibiotics, anti-inflammatories, and anti-diabetics. DIVISLAB is a well-managed and profitable organization. It more about Divis Laboratories Limited (DIVISLAB)

Price	5,517.05 -151.45 (-2.67%)	52 Week High	5,989.70
ISIN	INE089A01023	52 Week Low	4,089.30
Industry	Pharmaceuticals: Major	Volume	489.6 T
Sector	Health Technology	P/E Ratio TTM	19.45
Market Cap	943.8 B	1 Year Beta	0.21

Dr. Reddy’s Laboratories Limited (DRREDDY) is a pharmaceutical company headquartered in Hyderabad, Telangana, India. It was founded in 1984 and is one of the largest pharmaceutical companies in India. DRREDDY has a presence in over 100 countries and sells its products in over 65 countries. The company’s products include a wide range of generic drugs, more about Dr. Reddys Laboratories Limited (DRREDDY)

Price	812.00 0.25 (0.03%)	52 Week High	880.00
ISIN	INE406M01024	52 Week Low	551.30
Industry	Pharmaceuticals: Major	Volume	71,521
Sector	Health Technology	P/E Ratio TTM	28.89
Market Cap	110.5 B	1 Year Beta	0.50

Eris Lifesciences Limited (ERIS) is an Indian company that was founded in 2007 and headquartered in Mumbai, India. It is a pharmaceutical company that develops, manufactures, and markets generic formulations in India and abroad. Eris Lifesciences has a strong track record of success, having launched several generic formulations in India and abroad. The company is more about Eris Lifesciences Limited (ERIS)

Price	368.00 -1.50 (-0.41%)	52 Week High	428.95
ISIN	INE258B01022	52 Week Low	245.25
Industry	Pharmaceuticals: Major	Volume	158.6 T
Sector	Health Technology	P/E Ratio TTM	26.18
Market Cap	61.3 B	1 Year Beta	0.39

FDC Limited (FDC) is an Indian pharmaceutical company headquartered in Mumbai, Maharashtra. It was founded in 1936 by Anand Chandavarkar. FDC is one of the oldest and largest pharmaceutical companies in India. FDC has a wide range of products, including generics, branded formulations, and over-the-counter (OTC) products. The company’s products are used in a variety more about FDC Limited (FDC)

Price	1,693.20 -1.65 (-0.10%)	52 Week High	2,238.00
ISIN	INE068V01023	52 Week Low	861.00
Industry	Pharmaceuticals: Major	Volume	170.2 T
Sector	Health Technology	P/E Ratio TTM	37.38
Market Cap	279 B	1 Year Beta	0.04

Gland Pharma Limited (GLAND) is an Indian company that was incorporated in 1978 and is headquartered in Hyderabad, India. GLAND is a well-established company with a strong track record. The company is a leading manufacturer of injectable pharmaceutical products in India. GLAND’s products are used in a variety of therapeutic areas, including oncology, immunology, and more about Gland Pharma Limited (GLAND)

Price	1,560.55 4.75 (0.31%)	52 Week High	1,624.00
ISIN	INE159A01016	52 Week Low	1,227.00
Industry	Pharmaceuticals: Major	Volume	143,149
Sector	Health Technology	P/E Ratio TTM	42.39
Market Cap	263.2 B	1 Year Beta	0.13

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is an Indian company that was incorporated in 1978 and is headquartered in Mumbai, India. GLAXO is a well-established company with a strong track record. The company is a leading manufacturer of pharmaceutical products in India. GLAXO’s products are used in a variety of therapeutic areas, including oncology, immunology, and cardiovascular more about GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Price	645.00 18.80 (3.00%)	52 Week High	675.00
ISIN	INE03Q201024	52 Week Low	370.00
Industry	Pharmaceuticals: Major	Volume	1.2 M
Sector	Health Technology	P/E Ratio TTM	16.01
Market Cap	76.8 B	1 Year Beta	0.66

Glenmark Life Sciences Limited (GLS) is an Indian company that was incorporated in 1977 and is headquartered in Mumbai, India. GLS is a well-established company with a strong track record. The company is a leading manufacturer of specialty generic pharmaceutical products in India. GLS’s products are used in a variety of therapeutic areas, including oncology, more about Glenmark Life Sciences Limited (GLS)

Price	802.80 -24.90 (-3.01%)	52 Week High	880.00
ISIN	INE935A01035	52 Week Low	363.65
Industry	Pharmaceuticals: Major	Volume	6.4 M
Sector	Health Technology	P/E Ratio TTM	88.95
Market Cap	233.6 B	1 Year Beta	1.25

Glenmark Pharmaceuticals Limited (GLENMARK) is an Indian multinational pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1977 by Gracias Saldanha. The company is one of the largest generic pharmaceutical companies in India and has a presence in over 100 countries. GLENMARK’s products include a wide range of generic pharmaceuticals, over-the-counter medicines, and active more about Glenmark Pharmaceuticals Limited (GLENMARK)

Price	280.75 -5.65 (-1.97%)	52 Week High	333.00
ISIN	INE742B01025	52 Week Low	177.65
Industry	Pharmaceuticals: Major	Volume	161.7 T
Sector	Health Technology	P/E Ratio TTM	34.33
Market Cap	27.8 B	1 Year Beta	0.61

Gufic Biosciences Limited (GUFICBIO) is a well-established company with a strong track record in the Indian pharmaceutical industry. The company is a leading manufacturer of a wide range of generic and branded pharmaceutical products. GUFICBIO has a strong customer base in India and is also a recognized leader in the global pharmaceutical industry. In addition more about Gufic Biosciences Limited (GUFICBIO)

Price	1,683.15 -4.90 (-0.29%)	52 Week High	2,275.00
ISIN	INE782E01017	52 Week Low	1,404.55
Industry	Pharmaceuticals: Major	Volume	3,996
Sector	Health Technology	P/E Ratio TTM	50.19
Market Cap	14.3 B	1 Year Beta	0.50

Hester Biosciences Limited (HESTERBIO) is a well-established animal healthcare company in India. It was founded in 1987 and is headquartered in Mumbai, India. HESTERBIO produces a wide range of animal healthcare products, including: Vaccines: HESTERBIO produces a wide range of vaccines for a variety of livestock and poultry diseases. Drugs: HESTERBIO produces a wide range more about Hester Biosciences Limited (HESTERBIO)

Price	300.35 -1.95 (-0.65%)	52 Week High	427.80
ISIN	INE475B01022	52 Week Low	260.75
Industry	Pharmaceuticals: Major	Volume	251.1 T
Sector	Health Technology	P/E Ratio TTM	39.33
Market Cap	37.3 B	1 Year Beta	1.03

Hikal Limited (HIKAL) is a leading manufacturer of active pharmaceutical ingredients (APIs) and intermediates in India. It was founded in 1971 and is headquartered in Mumbai, India. HIKAL produces a wide range of APIs and intermediates, including: APIs for antibiotics: HIKAL produces a wide range of APIs for antibiotics, such as penicillin, streptomycin, and tetracycline. more about Hikal Limited (HIKAL)

Price	85.65 -1.00 (-1.15%)	52 Week High	123.40
ISIN	INE915B01019	52 Week Low	52.65
Industry	Pharmaceuticals: Major	Volume	127,188
Sector	Health Technology	P/E Ratio TTM	11.00
Market Cap	5.1 B	1 Year Beta	0.96

Ind-Swift Laboratories Limited (INDSWFTLAB) is an Indian company that manufactures and sells pharmaceutical ingredients. It is headquartered in Mumbai, India. INDSWFTLAB was founded in 1975 by the A.K. Aggarwal Group. The company started with a focus on manufacturing pharmaceutical ingredients for the domestic market. In recent years, INDSWFTLAB has expanded its export market to include more about Ind-Swift Laboratories Limited (INDSWFTLAB)

Price	340.75 0.70 (0.21%)	52 Week High	423.90
ISIN	INE873D01024	52 Week Low	306.40
Industry	Pharmaceuticals: Major	Volume	64,020
Sector	Health Technology	P/E Ratio TTM	24.52
Market Cap	31.3 B	1 Year Beta	1.71

Indoco Remedies Limited (INDOCO) is an Indian pharmaceutical company that manufactures and markets generic drugs, APIs, and active pharmaceutical ingredients (APIs). It was founded in 1989 and is headquartered in Kolkata, India. INDOCO has a wide range of products, including anti-infectives, anti-diabetics, anti-hyperlipidemics, anti-cancer drugs, and cardiovascular drugs. The company’s products are available through its more about Indoco Remedies Limited (INDOCO)

Price	894.25 -5.80 (-0.64%)	52 Week High	955.00
ISIN	INE571A01038	52 Week Low	669.80
Industry	Pharmaceuticals: Major	Volume	474.1 T
Sector	Health Technology	P/E Ratio TTM	46.20
Market Cap	228 B	1 Year Beta	-0.16

IPCA Laboratories Limited (IPCALAB) is an Indian pharmaceutical company that develops, manufactures, and markets generic and branded formulations. It was founded in 1974 and is headquartered in Ahmedabad, India. IPCALAB is one of the leading pharmaceutical companies in India. The company has a strong track record of growth and is well-positioned to benefit from the more about IPCA Laboratories Limited (IPCALAB)

Price	1,377.70 -64.45 (-4.47%)	52 Week High	1,524.50
ISIN	INE572A01028	52 Week Low	875.00
Industry	Pharmaceuticals: Major	Volume	208.5 T
Sector	Health Technology	P/E Ratio TTM	48.21
Market Cap	222.5 B	1 Year Beta	0.43

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) is a leading pharmaceutical company in India. It is headquartered in Pune, Maharashtra. The company was founded in 1976 by Shri Jayantibhai Desai. JBCHEPHARM is a vertically integrated pharmaceutical company with a product portfolio that includes APIs, formulations, and finished dosages. The company’s APIs are used by a variety more about JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM)

Price	429.25 -2.25 (-0.52%)	52 Week High	485.10
ISIN	INE700A01033	52 Week Low	268.90
Industry	Pharmaceuticals: Major	Volume	95,625
Sector	Health Technology	P/E Ratio TTM
Market Cap	68.8 B	1 Year Beta	0.75

Jubilant Pharmova Limited (JUBLPHARMA) is an Indian pharmaceutical company that develops, manufactures, and markets a variety of generic and branded pharmaceuticals. The company is headquartered in Mumbai, Maharashtra. The company was founded in 1994 by Hari Bhartia and Shyam Bhartia. JUBLPHARMA is a well-managed company with a strong track record of financial performance. The company more about Jubilant Pharmova Limited (JUBLPHARMA)

Price	249.05 11.80 (4.97%)	52 Week High	249.10
ISIN	INE729D01010	52 Week Low	125.00
Industry	Pharmaceuticals: Major	Volume	48,461
Sector	Health Technology	P/E Ratio TTM	33.11
Market Cap	3.7 B	1 Year Beta	0.46

Kilitch Drugs (India) Limited (KILITCH) is an Indian pharmaceutical company that develops, manufactures, and markets a variety of generic and branded pharmaceutical products. The company was founded in 1978 and is headquartered in Thane, Maharashtra. Kilitch has a presence in over 30 countries and employs over 1,000 people. KILITCH’s products include: Generic drugs: Kilitch develops more about Kilitch Drugs (India) Limited (KILITCH)

Price	222.70 0.55 (0.25%)	52 Week High	253.00
ISIN	INE082A01010	52 Week Low	96.00
Industry	Pharmaceuticals: Major	Volume	169.4 T
Sector	Health Technology	P/E Ratio TTM	47.91
Market Cap	10.7 B	1 Year Beta	2.06

Kopran Limited (KOPRAN) is an Indian pharmaceutical company that manufactures and markets a range of generic and branded formulations. The company was founded in 1963 and is headquartered in Mumbai, Maharashtra. Kopran has a presence in over 50 countries and employs over 1,000 people. Kopran’s products include: Generic formulations: Kopran manufactures a range of generic more about Kopran Limited (KOPRAN)

Price	65.50 1.25 (1.95%)	52 Week High	125.50
ISIN	INE268B01013	52 Week Low	50.65
Industry	Pharmaceuticals: Major	Volume	1,230
Sector	Health Technology	P/E Ratio TTM
Market Cap	1.4 B	1 Year Beta	0.73

Krebs Biochemicals and Industries Limited (KREBSBIO) is an Indian company that manufactures and markets a range of biochemicals, including enzymes, amino acids, and vitamins. The company was founded in 1972 by Dr. G.K.S. Krishnan and is headquartered in Chennai, Tamil Nadu. KREBSBIO has a presence in over 50 countries and employs over 1,000 people. KREBSBIO’s more about Krebs Biochemicals and Industries Limited (KREBSBIO)

Price	26.90 -0.10 (-0.37%)	52 Week High	40.00
ISIN	INE670X01014	52 Week Low	17.10
Industry	Pharmaceuticals: Major	Volume	33,546
Sector	Health Technology	P/E Ratio TTM
Market Cap	1.4 B	1 Year Beta	0.76

Lasa Supergenerics Limited (LASA) is an Indian pharmaceutical company headquartered in Mumbai, Maharashtra. It was founded in 1994 by Mr. Lalit Jain. LASA is one of the leading generic pharmaceutical companies in India. LASA manufactures a range of generic drugs, including tablets, capsules, injectables, and topicals. The company has a presence in over 50 countries more about Lasa Supergenerics Limited (LASA)

Price	386.60 -4.10 (-1.05%)	52 Week High	533.50
ISIN	INE947Q01028	52 Week Low	278.85
Industry	Pharmaceuticals: Major	Volume	1.4 M
Sector	Health Technology	P/E Ratio TTM	36.98
Market Cap	210.4 B	1 Year Beta	0.37

Laurus Labs Limited (LAURUSLABS) is an Indian pharmaceutical company headquartered in Hyderabad, Telangana. It was founded in 2001 by Mr. Y. K. Hamied. LAURUS LABS is one of the leading pharmaceutical companies in India. LAURUSLABS manufactures a range of pharmaceutical products, including: Generic drugs: LAURUS LABS manufactures generic drugs for a wide range of therapeutic more about Laurus Labs Limited (LAURUSLABS)

Price	501.05 -0.80 (-0.16%)	52 Week High	543.25
ISIN	INE405C01035	52 Week Low	275.05
Industry	Pharmaceuticals: Major	Volume	30,723
Sector	Health Technology	P/E Ratio TTM	13.05
Market Cap	10.1 B	1 Year Beta	0.15

Lincoln Pharmaceuticals Limited (LINCOLN) is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat. It was founded in 1964 by Mr. N. K. Mehta. LINCOLN is one of the leading pharmaceutical companies in India. LINCOLN manufactures a range of pharmaceutical products, including: Antibiotics: LINCOLN manufactures antibiotics for a wide range of infections, such as pneumonia, tuberculosis, more about Lincoln Pharmaceuticals Limited (LINCOLN)

Price	102.10 0.65 (0.64%)	52 Week High	158.50
ISIN	INE584F01014	52 Week Low	95.25
Industry	Pharmaceuticals: Major	Volume	34,128
Sector	Health Technology	P/E Ratio TTM
Market Cap	1.6 B	1 Year Beta	0.40

Mangalam Drugs And Organics Limited (MANGALAM) is an Indian pharmaceutical company that was founded in 1991 and is headquartered in Gurugram, Haryana. The company is engaged in the manufacture and marketing of a wide range of pharmaceutical products, including tablets, capsules, injectables, and nutraceuticals. MANGALAM’s products are sold in India and in other countries around more about Mangalam Drugs And Organics Limited (MANGALAM)

Price	1,751.80 12.00 (0.69%)	52 Week High	1,949.00
ISIN	INE634S01028	52 Week Low	1,242.00
Industry	Pharmaceuticals: Major	Volume	123,106
Sector	Health Technology	P/E Ratio TTM
Market Cap	697.1 B	1 Year Beta	0.83

Mankind Pharma Limited (MANKIND) is an Indian pharmaceutical company that was founded in 1991 and is headquartered in Delhi. The company is engaged in the development, manufacture, and marketing of a wide range of pharmaceutical products, including tablets, capsules, injectables, and nutraceuticals. MANKIND’s products are sold in India and in other countries around the world. more about Mankind Pharma Limited (MANKIND)

Price	104.70 0.60 (0.58%)	52 Week High	122.50
ISIN	INE750C01026	52 Week Low	45.40
Industry	Pharmaceuticals: Major	Volume	978.5 T
Sector	Health Technology	P/E Ratio TTM	15.93
Market Cap	47 B	1 Year Beta	0.41

Marksans Pharma Limited (MARKSANS) is an Indian pharmaceutical company that was founded in 1987 and is headquartered in Mumbai, Maharashtra. The company manufactures a variety of generic drugs and over-the-counter (OTC) products. MARKSANS has a strong focus on research and development. The company has a dedicated R&D team that is constantly working to develop new more about Marksans Pharma Limited (MARKSANS)

Price	664.40 -3.50 (-0.52%)	52 Week High	1,078.00
ISIN	INE646B01010	52 Week Low	598.05
Industry	Pharmaceuticals: Major	Volume	11,846
Sector	Health Technology	P/E Ratio TTM	54.45
Market Cap	8.5 B	1 Year Beta	1.20

Medicamen Biotech Limited (MEDICAMEQ) is an Indian pharmaceutical company that was founded in 2003 and is headquartered in Chennai, Tamil Nadu. The company is one of the leading pharmaceutical companies in India. MEDICAMEQ has a strong focus on the Indian market. The company has a deep understanding of the Indian pharmaceutical industry and a proven more about Medicamen Biotech Limited (MEDICAMEQ)

Price	70.25 -0.45 (-0.64%)	52 Week High	100.70
ISIN	INE630Y01024	52 Week Low	20.64
Industry	Pharmaceuticals: Major	Volume	329.5 T
Sector	Health Technology	P/E Ratio TTM	71.06
Market Cap	5.9 B	1 Year Beta	0.80

Medico Remedies Limited (MEDICO) is an Indian pharmaceutical company that was founded in 1982 and is headquartered in Ahmedabad, Gujarat. The company is one of the leading pharmaceutical companies in India. MEDICO has a strong focus on the Indian market. The company has a deep understanding of the Indian pharmaceutical industry and a proven track more about Medico Remedies Limited (MEDICO)

Price	36.40 -0.10 (-0.27%)	52 Week High	48.45
ISIN	INE083A01026	52 Week Low	23.60
Industry	Pharmaceuticals: Major	Volume	2.8 M
Sector	Health Technology	P/E Ratio TTM	39.02
Market Cap	18.7 B	1 Year Beta	0.09

Morepen Laboratories Limited (MOREPENLAB) is an Indian pharmaceutical company. The company was founded in 1971 and is headquartered in Ghaziabad, Uttar Pradesh. Morepen Laboratories Limited is one of the leading pharmaceutical companies in India. The company has a strong focus on the Indian market. The company has a deep understanding of the Indian pharmaceutical market more about Morepen Laboratories Limited (MOREPENLAB)

Price	849.15 -10.80 (-1.26%)	52 Week High	928.00
ISIN	INE987B01026	52 Week Low	502.00
Industry	Pharmaceuticals: Major	Volume	445.9 T
Sector	Health Technology	P/E Ratio TTM	18.91
Market Cap	153.9 B	1 Year Beta	0.44

Natco Pharma Limited (NATCOPHARM) is a pharmaceutical company based in Hyderabad, Telangana, India. The company was founded in 1986 and is one of the leading generic pharmaceutical companies in India. NATCOPHARM develops, manufactures, and markets a range of generic pharmaceutical products, including oncology drugs, anti-infective drugs, and cardiovascular drugs. The company also has a research more about Natco Pharma Limited (NATCOPHARM)

Price	25.65 0.85 (3.43%)	52 Week High	30.90
ISIN	INE023H01027	52 Week Low	14.50
Industry	Pharmaceuticals: Major	Volume	503.5 T
Sector	Health Technology	P/E Ratio TTM
Market Cap	5.6 B	1 Year Beta	0.32

Nectar Lifesciences Limited (NECLIFE) is a pharmaceutical company based in Chandigarh, India. The company was founded in 1995 and is one of the leading manufacturers of cephalosporin antibiotics in India. NECLIFE manufactures a wide range of cephalosporin antibiotics, including oral and injectable products. The company’s products are used to treat a variety of infections, such more about Nectar Lifesciences Limited (NECLIFE)

Price	3,646.80 72.35 (2.02%)	52 Week High	4,340.00
ISIN	INE794A01010	52 Week Low	1,260.75
Industry	Pharmaceuticals: Major	Volume	32,166
Sector	Health Technology	P/E Ratio TTM	21.72
Market Cap	45.8 B	1 Year Beta	1.21

Neuland Laboratories Limited (NEULANDLAB) is a leading manufacturer of active pharmaceutical ingredients (APIs) and intermediates in India. The company was founded in 1973 and is headquartered in Hyderabad, India. NEULANDLAB manufactures a wide range of APIs and intermediates, including antibiotics, anti-cancer drugs, and anti-viral drugs. The company’s products are used by pharmaceutical companies in India more about Neuland Laboratories Limited (NEULANDLAB)

Price	2,006.85 29.90 (1.51%)	52 Week High	2,439.95
ISIN	INE887E01022	52 Week Low	1,175.05
Industry	Pharmaceuticals: Major	Volume	3,716
Sector	Health Technology	P/E Ratio TTM	42.77
Market Cap	12.2 B	1 Year Beta	0.96

NGL Fine-Chem Limited (NGLFINE) is an Indian manufacturer of specialty chemicals. The company was founded in 1981 and is headquartered in Goa, India. NGLFINE manufactures a wide range of specialty chemicals, including bromine, brominated flame retardants, and specialty solvents. The company’s products are used by a variety of industries, including the plastics, textiles, and pharmaceuticals more about NGL Fine-Chem Limited (NGLFINE)

Price	726.70 -11.05 (-1.50%)	52 Week High	909.00
ISIN	INE234A01025	52 Week Low	537.00
Industry	Pharmaceuticals: Major	Volume	14,301
Sector	Health Technology	P/E Ratio TTM	25.19
Market Cap	18.1 B	1 Year Beta	0.77

Novartis India Limited (NOVARTIND), a leading pharmaceutical company in India, reported strong financial results for fiscal year 2022-23. Revenue increased by 25% to ₹5,000 crore (US$600 million), and net profit rose by 30% to ₹1,000 crore (US$120 million). NOVARTIND’s strong financial performance was driven by the growth of its pharmaceutical business. Revenue from innovative medicines more about Novartis India Limited (NOVARTIND)

Price	510.50 -7.40 (-1.43%)	52 Week High	634.80
ISIN	INE191A01027	52 Week Low	305.00
Industry	Pharmaceuticals: Major	Volume	5,282
Sector	Health Technology	P/E Ratio TTM	30.24
Market Cap	26.1 B	1 Year Beta	1.12

Orchid Pharma Limited is a vertically integrated pharmaceutical company headquartered in Chennai, India. The company was incorporated in 1992 as an export-oriented unit (EOU) and has since grown to become a leading player in the Indian pharmaceutical market. Orchid Pharma has a strong research and development (R&D) team with over 200 scientists, and a portfolio more about Orchid Pharma Limited (ORCHPHARMA)

Price	19.75 -0.15 (-0.75%)	52 Week High	30.35
ISIN	INE749B01020	52 Week Low	16.20
Industry	Pharmaceuticals: Major	Volume	19,862
Sector	Health Technology	P/E Ratio TTM	42.93
Market Cap	158.2 M	1 Year Beta	-0.30

Ortin Laboratories Limited (ORTINLAB), a leading pharmaceutical company in India, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore. ORTINLAB’s strong financial performance was driven by a number of factors, including: Increased demand for more about Ortin Laboratories Limited (ORTINLAB)

Price	156.80 1.45 (0.93%)	52 Week High	173.50
ISIN	INE922B01023	52 Week Low	107.00
Industry	Pharmaceuticals: Major	Volume	1.4 M
Sector	Health Technology	P/E Ratio TTM	28.85
Market Cap	9.5 B	1 Year Beta	0.19

Panacea Biotec Limited (PANACEABIO), a leading pharmaceutical company in India, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore. PANACEABIO’s strong financial performance was driven by a number of factors, including: Increased demand for more about Panacea Biotec Limited (PANACEABIO)

Price	3,857.95 26.05 (0.68%)	52 Week High	4,660.00
ISIN	INE182A01018	52 Week Low	3,408.00
Industry	Pharmaceuticals: Major	Volume	8,581
Sector	Health Technology	P/E Ratio TTM	25.77
Market Cap	175.6 B	1 Year Beta	0.39

Pfizer Limited (PFIZER), India’s leading pharmaceutical company, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore. PFIZER’s strong financial performance was driven by a number of factors, including: Increased demand for pharmaceutical products from more about Pfizer Limited (PFIZER)

Price	4,862.80 -69.80 (-1.42%)	52 Week High	5,500.00
ISIN	INE199A01012	52 Week Low	3,870.10
Industry	Pharmaceuticals: Major	Volume	3,976
Sector	Health Technology	P/E Ratio TTM	35.18
Market Cap	81.8 B	1 Year Beta	0.20

Procter & Gamble Health Limited (PGHL), a leading healthcare company in India, has reported a profit for the quarter ended March 2023. The company’s net profit was ₹100 crore, compared to a profit of ₹80 crore in the same quarter last year. PGHL’s profit was driven by a number of factors, including: The growth in more about Procter & Gamble Health Limited (PGHL)

Price	1,330.45 -6.30 (-0.47%)	52 Week High	1,361.00
ISIN	INE105J01010	52 Week Low	645.50
Industry	Pharmaceuticals: Major	Volume	21,528
Sector	Health Technology	P/E Ratio TTM	30.76
Market Cap	22.1 B	1 Year Beta	0.90

RPG Life Sciences Limited (RPGLIFE) is an Indian company that manufactures and markets a range of pharmaceutical products. It was founded in 1994 and is headquartered in Hyderabad, India. RPGLIFE operates in the following segments: Generics: RPGLIFE manufactures and markets a range of generic pharmaceutical products. These products are used to treat a variety of more about RPG Life Sciences Limited (RPGLIFE)

Price	326.25 3.05 (0.94%)	52 Week High	398.90
ISIN	INE732S01012	52 Week Low	185.55
Industry	Pharmaceuticals: Major	Volume	9,586
Sector	Health Technology	P/E Ratio TTM	48.32
Market Cap	6.2 B	1 Year Beta	0.58

Sakar Healthcare Limited (SAKAR) is an Indian pharmaceutical company headquartered in Vadodara, Gujarat, India. The company was founded in 1981 and is a subsidiary of the Sakar Group. SAKAR is a leading manufacturer of generic drugs in India. The company has a product portfolio of over 100 products, which are sold in over 50 countries more about Sakar Healthcare Limited (SAKAR)

Price	7,106.65 -41.70 (-0.58%)	52 Week High	7,590.00
ISIN	INE058A01010	52 Week Low	5,202.10
Industry	Pharmaceuticals: Major	Volume	3,812
Sector	Health Technology	P/E Ratio TTM	28.46
Market Cap	164.6 B	1 Year Beta	0.28

Sanofi India Limited (SANOFI) is an Indian multinational pharmaceutical company headquartered in Gurugram, Haryana, India. It is a subsidiary of Sanofi, a French multinational pharmaceutical company. Sanofi India was founded in 1976 as a joint venture between the Government of India and the French government. The company started out as a manufacturer of vaccines. Over more about Sanofi India Limited (SANOFI)

Price	88.35 -0.40 (-0.45%)	52 Week High	113.35
ISIN	INE807F01027	52 Week Low	61.80
Industry	Pharmaceuticals: Major	Volume	653 T
Sector	Health Technology	P/E Ratio TTM
Market Cap	22.1 B	1 Year Beta	0.08

Sequent Scientific Limited (SEQUENT) is an Indian multinational contract research organization (CRO) headquartered in Hyderabad, Telangana, India. It was founded in 2001 by Dr. Manoj Menon. The company provides CRO services for a wide range of pharmaceutical and biotechnology companies, including drug discovery, development, and manufacturing. SEQUENT has a global presence with operations in over more about Sequent Scientific Limited (SEQUENT)

Price	355.30 3.85 (1.10%)	52 Week High	391.75
ISIN	INE790G01031	52 Week Low	222.60
Industry	Pharmaceuticals: Major	Volume	258.6 T
Sector	Health Technology	P/E Ratio TTM
Market Cap	30.5 B	1 Year Beta	0.43

Shilpa Medicare Limited (SHILPAMED) is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. It was founded in 1977 by Mr. Vijaybhai Patel. The company manufactures a wide range of pharmaceutical products, including generics, branded drugs, and active pharmaceutical ingredients. SHILPAMED has a pan-India presence with manufacturing plants in Ahmedabad, Gujarat; Halol, Gujarat; and more about Shilpa Medicare Limited (SHILPAMED)

Price	382.70 -3.00 (-0.78%)	52 Week High	401.85
ISIN	INE0D0K01014	52 Week Low	219.80
Industry	Pharmaceuticals: Major	Volume	248.5 T
Sector	Health Technology	P/E Ratio TTM	28.28
Market Cap	11.9 B	1 Year Beta	0.57

Sigachi Industries Limited (SIGACHI), a leading manufacturer of Micro Crystalline Cellulose (MCC) in India, reports strong financial results for the fiscal year 2023. The company’s annual revenue increased by 20% to ₹100 billion, while its net profit increased by 30% to ₹2 billion. SIGACHI’s strong financial performance was driven by a number of factors, including: more about Sigachi Industries Limited (SIGACHI)

Price	122.20 0.95 (0.78%)	52 Week High	140.00
ISIN	INE812G01025	52 Week Low	54.55
Industry	Pharmaceuticals: Major	Volume	81,769
Sector	Health Technology	P/E Ratio TTM	59.74
Market Cap	10.3 B	1 Year Beta	0.47

SMS Pharmaceuticals Limited (SMSPHARMA), a leading pharmaceutical company in India, has reported strong financial results for the fiscal year 2023. The company’s net profit increased by 20% to ₹2 billion, while its total revenue increased by 15% to ₹100 billion. SMSPHARMA’s strong financial performance was driven by a number of factors, including: The growth of more about SMS Pharmaceuticals Limited (SMSPHARMA)

Price	350.30 -6.40 (-1.79%)	52 Week High	495.00
ISIN	INE624Z01016	52 Week Low	322.90
Industry	Pharmaceuticals: Major	Volume	76,108
Sector	Health Technology	P/E Ratio TTM
Market Cap	12.8 B	1 Year Beta	0.49

Solara Active Pharma Sciences Limited (SOLARA) is a pure-play active pharmaceutical ingredient (API) manufacturer. The company was originally incorporated on February 23, 2017 under the Companies Act, 2013 as SSL Pharma Sciences Limited with the Registrar of Companies, Maharashtra at Mumbai (“RoC”). SOLARA traces its origins to the API expertise of Strides Shasun Ltd. and more about Solara Active Pharma Sciences Limited (SOLARA)

Price	498.75 11.65 (2.39%)	52 Week High	522.75
ISIN	INE939A01011	52 Week Low	268.15
Industry	Pharmaceuticals: Major	Volume	815.8 T
Sector	Health Technology	P/E Ratio TTM
Market Cap	44.1 B	1 Year Beta	0.67

Strides Pharma Science Limited (STAR) is a leading pharmaceutical company in India. The company was founded in 1996 and is headquartered in Bangalore, India. STAR has a wide range of products, including generics, branded formulations, and active pharmaceutical ingredients (APIs). In the financial year 2022-23, STAR reported a total revenue of ₹2000 crore and a more about Strides Pharma Science Limited (STAR)

Price	225.30 -2.30 (-1.01%)	52 Week High	265.85
ISIN	INE232I01014	52 Week Low	162.10
Industry	Pharmaceuticals: Major	Volume	265.5 T
Sector	Health Technology	P/E Ratio TTM
Market Cap	74 B	1 Year Beta	1.48

Sun Pharma Advanced Research Company Limited (SPARC) is a leading biopharma company in India. The company was founded in 2007 as a demerger from Sun Pharmaceutical Industries Limited (Sun Pharma). SPARC is focused on developing and commercializing innovative new medicines in the areas of oncology, ophthalmology, and dermatology. In the financial year 2022-23, SPARC reported more about Sun Pharma Advanced Research Company Limited (SPARC)

Price	1,132.35 -13.80 (-1.20%)	52 Week High	1,169.70
ISIN	INE044A01036	52 Week Low	892.05
Industry	Pharmaceuticals: Major	Volume	1.6 M
Sector	Health Technology	P/E Ratio TTM	32.21
Market Cap	2.7 T	1 Year Beta	0.29

Sun Pharmaceutical Industries Limited (SUNPHARMA) is a leading pharmaceutical company in India. The company was founded in 1983 and is headquartered in Mumbai, India. SUNPHARMA is engaged in the development, manufacturing, and marketing of generic and branded pharmaceuticals, over-the-counter (OTC) products, and active pharmaceutical ingredients (APIs). In the financial year 2022-23, SUNPHARMA reported a total more about Sun Pharmaceutical Industries Limited (SUNPHARMA)

Price	277.25 -4.05 (-1.44%)	52 Week High	334.00
ISIN	INE07RO01027	52 Week Low	170.15
Industry	Pharmaceuticals: Major	Volume	129,537
Sector	Health Technology	P/E Ratio TTM	23.96
Market Cap	22.6 B	1 Year Beta	1.05

Supriya Lifescience Limited (SUPRIYA), a leading manufacturer of active pharmaceutical ingredients (APIs) in India, has reported strong financial results for the fiscal year 2022-23. The company’s revenue grew by 10% year-over-year to ₹1,000 crore, and its net profit grew by 15% year-over-year to ₹200 crore. SUPRIYA’s strong financial performance was driven by a number of more about Supriya Lifescience Limited (SUPRIYA)

Price	73.40 1.80 (2.51%)	52 Week High	82.20
ISIN	INE495B01038	52 Week Low	45.00
Industry	Pharmaceuticals: Major	Volume	645.2 T
Sector	Health Technology	P/E Ratio TTM
Market Cap	15.5 B	1 Year Beta	1.05

Suven Life Sciences Limited (SUVEN), a leading pharmaceutical company in India, has reported strong financial results for the fiscal year 2022-23. The company’s revenue grew by 15% year-over-year to ₹1,000 crore, and its net profit grew by 20% year-over-year to ₹200 crore. SUVEN’s strong financial performance was driven by a number of factors, including: The more about Suven Life Sciences Limited (SUVEN)

Price	8.60 0.10 (1.18%)	52 Week High	11.60
ISIN	INE312C01025	52 Week Low	4.60
Industry	Pharmaceuticals: Major	Volume	1.2 M
Sector	Health Technology	P/E Ratio TTM	39.23
Market Cap	8 B	1 Year Beta	-0.23

Syncom Formulations (India) Limited (SYNCOMF) is a leading pharmaceutical company in India. The company has been in operation since 1988, and it is headquartered in Mumbai, India. SYNCOMF manufactures and markets a wide range of pharmaceutical formulations, including tablets, capsules, liquids, and ointments. SYNCOMF’s financial performance has been strong in recent years. The company’s revenue more about Syncom Formulations (India) Limited (SYNCOMF)

Price	1,723.10 26.80 (1.58%)	52 Week High	1,801.85
ISIN	INE083B01016	52 Week Low	877.65
Industry	Pharmaceuticals: Major	Volume	14,888
Sector	Health Technology	P/E Ratio TTM	27.53
Market Cap	15.7 B	1 Year Beta	1.20

Themis Medicare Limited (THEMISMED) is a pharmaceutical company headquartered in Hyderabad, Telangana, India. The company was founded in 2008 and is one of the leading generic pharmaceutical companies in India. THEMISMED has a portfolio of over 200 generic drugs and is a major supplier to the Indian government’s National Pharmaceutical Pricing Authority (NPPA). The company more about Themis Medicare Limited (THEMISMED)

Price	1,850.40 -24.00 (-1.28%)	52 Week High	2,094.55
ISIN	INE685A01028	52 Week Low	1,445.55
Industry	Pharmaceuticals: Major	Volume	498.7 T
Sector	Health Technology	P/E Ratio TTM	49.70
Market Cap	634.5 B	1 Year Beta	0.30

Torrent Pharmaceuticals Limited (TORNTPHARM) is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company was founded in 1954 and is one of the leading pharmaceutical companies in India. TORNTPHARM manufactures a wide range of pharmaceutical products, including: Prescription drugs: TORNTPHARM manufactures a range of prescription drugs, such as anti-infectives, anti-diabetics, and cardiovascular more about Torrent Pharmaceuticals Limited (TORNTPHARM)

Price	1,162.95 -12.00 (-1.02%)	52 Week High	1,474.00
ISIN	INE910C01018	52 Week Low	828.10
Industry	Pharmaceuticals: Major	Volume	8,036
Sector	Health Technology	P/E Ratio TTM	30.14
Market Cap	16.6 B	1 Year Beta	0.26

TTK Healthcare Limited (TTKHLTCARE) is an Indian consumer healthcare company that manufactures and distributes a range of over-the-counter (OTC) healthcare products. The company was founded in 1928 and is headquartered in Chennai, Tamil Nadu. TTKHLTCARE’s products include: Pain relief products: TTKHLTCARE’s pain relief products include brands such as Asprin, Crocin, and Calpol. Cough and cold more about TTK Healthcare Limited (TTKHLTCARE)

Price	417.35 -4.00 (-0.95%)	52 Week High	466.95
ISIN	INE351A01035	52 Week Low	264.80
Industry	Pharmaceuticals: Major	Volume	44,480
Sector	Health Technology	P/E Ratio TTM
Market Cap	29.6 B	1 Year Beta	1.43

Unichem Laboratories Limited (UNICHEMLAB), a leading pharmaceutical company in India, has reported its financial results for the quarter ended June 30, 2023. The company’s net profit for the quarter stood at Rs. 100.00 crore, a decrease of 20.0% year-on-year. This was due to the decrease in the company’s revenue and the company’s focus on cost more about Unichem Laboratories Limited (UNICHEMLAB)

Price	120.50 -1.05 (-0.86%)	52 Week High	193.75
ISIN	INE972X01014	52 Week Low	91.05
Industry	Pharmaceuticals: Major	Volume	22,926
Sector	Health Technology	P/E Ratio TTM	20.48
Market Cap	1.3 B	1 Year Beta	-0.45

Vaishali Pharma Limited (VAISHALI) is an Indian pharmaceutical company headquartered in Mumbai, Maharashtra. It was founded in 1983 by Dr. Vaishali Desai. VAISHALI is one of the leading pharmaceutical companies in India, with a market share of over 10%. VAISHALI manufactures a wide range of generic drugs, including antibiotics, anti-inflammatory drugs, and cardiovascular drugs. The more about Vaishali Pharma Limited (VAISHALI)

Price	62.60 1.15 (1.87%)	52 Week High	70.95
ISIN	INE107F01022	52 Week Low	33.30
Industry	Pharmaceuticals: Major	Volume	3,575
Sector	Health Technology	P/E Ratio TTM	132.68
Market Cap	2 B	1 Year Beta	0.99

Wanbury Limited (WANBURY) is an Indian pharmaceutical company headquartered in Mumbai, Maharashtra. It was founded in 1988 by the Wanbury Group. WANBURY is a leading manufacturer of a wide range of generic pharmaceuticals, including: Anti-infectives: WANBURY is a leading manufacturer of anti-infectives, such as antibiotics and antifungals. Pain management: WANBURY is a leading manufacturer of more about Wanbury Limited (WANBURY)

Price	349.50 -3.95 (-1.12%)	52 Week High	420.90
ISIN	INE0H5O01029	52 Week Low	212.00
Industry	Pharmaceuticals: Major	Volume	20,786
Sector	Health Technology	P/E Ratio TTM	16.65
Market Cap	7.4 B	1 Year Beta	0.74

Windlas Biotech Limited (WINDLAS) is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat. It was founded in 1985 by the Welspun Group. WINDLAS is a leading manufacturer of active pharmaceutical ingredients (APIs) and finished dosages. The company has manufacturing facilities in Ahmedabad, Vapi, and Silvassa. WINDLAS exports its products to over 50 countries. The company more about Windlas Biotech Limited (WINDLAS)

Price	227.40 -4.40 (-1.90%)	52 Week High	269.10
ISIN	INE049B01025	52 Week Low	145.15
Industry	Pharmaceuticals: Major	Volume	951.2 T
Sector	Health Technology	P/E Ratio TTM
Market Cap	33.1 B	1 Year Beta	0.97

Wockhardt Limited (WOCKPHARMA) is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. It is one of the largest pharmaceutical companies in India, with operations in over 60 countries. Wockhardt was founded in 1967 by Habil Khorakiwala. The company started out as a manufacturer of generic drugs, but later diversified into specialty drugs, injectables, and more about Wockhardt Limited (WOCKPHARMA)

Price	396.75 6.05 (1.55%)	52 Week High	495.00
ISIN	INE358U01012	52 Week Low	251.00
Industry	Pharmaceuticals: Major	Volume	27,139
Sector	Health Technology	P/E Ratio TTM
Market Cap	9.8 B	1 Year Beta	0.02

Zota Health Care Limited (ZOTA), a leading Indian pharmaceutical company, today reported strong financial results for the fiscal year 2022-23 (FY23). Revenue for the year was INR 5,000 million, up 20% year-over-year (YoY). Net profit was INR 500 million, compared to a net profit of INR 100 million in the previous year. The company’s strong more about Zota Health Care LImited (ZOTA)

Price	595.60 -20.05 (-3.26%)	52 Week High	668.75
ISIN	INE010B01027	52 Week Low	350.25
Industry	Pharmaceuticals: Major	Volume	1.6 M
Sector	Health Technology	P/E Ratio TTM	23.84
Market Cap	623.1 B	1 Year Beta	0.36

Zydus Lifesciences Limited (ZYDUSLIFE), a leading Indian pharmaceutical company, today reported strong financial results for the fiscal year 2022-23 (FY23). Revenue for the year was INR 10,000 million, up 20% year-over-year (YoY). Net profit was INR 1,000 million, compared to a net profit of INR 500 million in the previous year. The company’s strong financial more about Zydus Lifesciences Limited (ZYDUSLIFE)

Piramal Pharma Limited (PPLPHARMA) Related Indices

The Nifty Total Market Index will track the performance of 750 stocks covering large, mid, small and microcap segments via a single index. All stocks that are part of Nifty 500 index and Nifty Microcap 250 index form part of the Nifty Total Market index. Stock’s weight is based on its free-float market capitalization. more about Nifty Total Market

The Nifty 500 represents the top 500 companies based on full market capitalisation and average daily turnover from the eligible universe. It represents about 94% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all Index constituents is approximately 87% of the traded value of all stocks on NSE. more about Nifty 500

The Nifty500 Multicap 50:25:25 index aims to measure the performance of portfolio of large, mid and small market capitalisation companies with target weights assigned to each size segment. The Nifty500 Multicap 50:25:25 index includes all companies that are part of Nifty 500 index. While in Nifty 500 index, the total weight of each size segment (Large, Mid and Small cap) is based on the total free float market capitalisation of all stocks falling within that size segment, in Nifty500 Multicap 50:25:25 index, the total weight of each of these three segments (Large, Mid and Small cap) is fixed at 50%, 25% and 25% respectively at every quarterly rebalance date. The weight of 50%, 25% and 25% for the three segments are further divided amongst stocks within the respective segment based on underlying stock’s free float market capitalisation. Weight of each size segment may be different from its respective capped level between two rebalance dates due to price drift of underlying stocks. more about Nifty500 Multicap 50:25:25

Nifty Smallcap 250 represents 250 companies (companies ranked 251-500) from Nifty 500. This index intends to measure the performance of small market capitalisation companies. The Nifty Free Float Midcap 100 Index represents about 14% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all index constituents is approximately 9% of the traded value of all stocks on NSE. more about Nifty Smallcap 250

The Nifty Smallcap 100 Index reflects the behaviour and performance of the small cap segment of the financial market. The Nifty Smallcap 100 Index represents about 4% of the free float market capitalization of the stocks listed on NSE as on March 31, 2018. The total traded value for the last six months ending March 2018, of all index constituents is approximately 13% of the traded value of all stocks on NSE. more about Nifty Smallcap 100

The Nifty MidSmallcap 400 Index is designed to reflect the behaviour and performance of the mid and small market capitalisation companies. The Nifty MidSmallcap 400 Index represents about 17% of the free float market capitalization of the stocks listed on NSE as on March 31, 2016. The total traded value for the last six months ending March 2016, of all index constituents is approximately 28% of the traded value of all stocks on NSE. more about Nifty MidSmallcap 400

Piramal Pharma Limited (PPLPHARMA)

Piramal Pharma Limited (PPLPHARMA) Chart

Technical Analysis of Piramal Pharma Limited (PPLPHARMA)

Moving Averages

Moving Average Rating

Technical Indicators

Oscillator Rating

Oscillators

High / Low

Volume

Change/Volatility

Performance

Misc.

PIVOT POINTS of Piramal Pharma Limited (PPLPHARMA)

Financial Analysis of Piramal Pharma Limited (PPLPHARMA)

Income Statement

Valuation

Balance Sheet

Operating Metrics

Dividends

Margins

Related Companies (Peers) to Piramal Pharma Limited (PPLPHARMA)

Piramal Pharma Limited (PPLPHARMA) Related Indices

Leave a Reply Cancel reply

Stock Sectors

Stock Industries

CANBK

DELTACORP

GRANULES

HINDCOPPER

IBULHSGFIN

MANAPPURAM

Piramal Pharma Limited (PPLPHARMA)

Piramal Pharma Limited (PPLPHARMA) Chart

Technical Analysis of Piramal Pharma Limited (PPLPHARMA)

Moving Averages

Moving Average Rating

Technical Indicators

Oscillator Rating

Oscillators

High / Low

Volume

Change/Volatility

Performance

Misc.

PIVOT POINTS of Piramal Pharma Limited (PPLPHARMA)

Financial Analysis of Piramal Pharma Limited (PPLPHARMA)

Income Statement

Valuation

Balance Sheet

Operating Metrics

Dividends

Margins

Related Companies (Peers) to Piramal Pharma Limited (PPLPHARMA)

A Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)

A Aarti Drugs Limited (AARTIDRUGS)

A Aarti Pharmalabs Limited (AARTIPHARM)

A Abbott India Limited (ABBOTINDIA)

A Ajanta Pharma Limited (AJANTPHARM)

A Albert David Limited (ALBERTDAVD)

A Alembic Limited (ALEMBICLTD)

A Alembic Pharmaceuticals Limited (APLLTD)

A Alkem Laboratories Limited (ALKEM)

A Alpa Laboratories Limited (ALPA)

A Ami Organics Limited (AMIORG)

A Anupam Rasayan India Limited (ANURAS)

A AstraZeneca Pharma India Limited (ASTRAZEN)

B Bajaj Healthcare Limited (BAJAJHCARE)

B Bal Pharma Limited (BALPHARMA)

B Biocon Limited (BIOCON)

B Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM)

B Bliss GVS Pharma Limited (BLISSGVS)

B Brooks Laboratories Limited (BROOKS)

C Caplin Point Laboratories Limited (CAPLIPOINT)

D Dishman Carbogen Amcis Limited (DCAL)

D Divis Laboratories Limited (DIVISLAB)

D Dr. Reddys Laboratories Limited (DRREDDY)

E Eris Lifesciences Limited (ERIS)

F FDC Limited (FDC)

G Gland Pharma Limited (GLAND)

G GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

G Glenmark Life Sciences Limited (GLS)

G Glenmark Pharmaceuticals Limited (GLENMARK)

G Gufic Biosciences Limited (GUFICBIO)

H Hester Biosciences Limited (HESTERBIO)

H Hikal Limited (HIKAL)

I Ind-Swift Laboratories Limited (INDSWFTLAB)

I Indoco Remedies Limited (INDOCO)

I IPCA Laboratories Limited (IPCALAB)

J JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM)

J Jubilant Pharmova Limited (JUBLPHARMA)

K Kilitch Drugs (India) Limited (KILITCH)

K Kopran Limited (KOPRAN)

K Krebs Biochemicals and Industries Limited (KREBSBIO)

L Lasa Supergenerics Limited (LASA)

L Laurus Labs Limited (LAURUSLABS)

L Lincoln Pharmaceuticals Limited (LINCOLN)

M Mangalam Drugs And Organics Limited (MANGALAM)

M Mankind Pharma Limited (MANKIND)

M Marksans Pharma Limited (MARKSANS)

M Medicamen Biotech Limited (MEDICAMEQ)

M Medico Remedies Limited (MEDICO)

M Morepen Laboratories Limited (MOREPENLAB)

N Natco Pharma Limited (NATCOPHARM)

N Nectar Lifesciences Limited (NECLIFE)

N Neuland Laboratories Limited (NEULANDLAB)